SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Why do the majority of patients not respond at all, or only partially or transiently, to Immunotherapy?

Dalgleish, AG (2019) Why do the majority of patients not respond at all, or only partially or transiently, to Immunotherapy? Expert Review of Anticancer Therapy. ISSN 1473-7140 https://doi.org/10.1080/14737140.2019.1696676
SGUL Authors: Dalgleish, Angus George

[img] PDF Accepted Version
Restricted to Repository staff only until 25 November 2020.
Available under License ["licenses_description_publisher" not defined].

Download (921kB)
Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Anticancer Therapy on 25/11/19, available online: http://www.tandfonline.com/10.1080/14737140.2019.1696676.
Keywords: 1112 Oncology And Carcinogenesis, Oncology & Carcinogenesis
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Expert Review of Anticancer Therapy
ISSN: 1473-7140
Dates:
DateEvent
25 November 2019Published Online
12 November 2019Accepted
Publisher License: Publisher's own licence
URI: http://sgultest.da.ulcc.ac.uk/id/eprint/111427
Publisher's version: https://doi.org/10.1080/14737140.2019.1696676

Actions (login required)

Edit Item Edit Item